Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 113
Selected: 0
NCT IDTitle
NCT03034577Deep Neuromuscular Block for Laparoscopic Surgery
NCT06631872Implementing Surgery School Prehabilitation Using Telehealth
NCT05521412EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T
NCT04801966Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
NCT03874884177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer
NCT03658447PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr)
NCT06414148MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma
NCT04343885In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy
NCT01500538A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)
NCT07387978A Study to Describe the Effect of Photobiomodulation (Low Level Laser Therapy) in Reducing the Severity and Incidence of Oral Mucositis (Oral Ulceration) in Oral Cancer Patients Undergoing Radiation Treatment
NCT03980171Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma
NCT05340374Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer
NCT03900884Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
NCT03429387PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia
NCT05063838Perioperative Pharmacogenomic Testing
NCT07527819Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)
NCT05383079Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer
NCT01658241Panobinostat Biological Correlates Study
NCT05592938Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
NCT00206609The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer
NCT04074460Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study
NCT00434239Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia
NCT02506556Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer
NCT04985721A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects
NCT05878288Deep sequencIng in Cutaneous Squamous CEll caRciNomas
NCT04234061Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma
NCT07090369Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer
NCT00098995Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
NCT05366153Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer
NCT07541391Autologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen (KMA) in Kappa Restricted Multiple Myeloma Patients With Relapsed/Refractory Disease
NCT04914741A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)
NCT05024318NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma
NCT07213076Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.
NCT00418210Accelerated Partial Breast Irradiation for Early Breast Cancer
NCT04769817ProsTIC Registry of Men Treated With PSMA Theranostics
NCT00351598Lung Tumour Volume Database
NCT01493206A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer
NCT07241715Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)
NCT05560659Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
NCT04430192Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy
NCT05864742Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma
NCT05169177Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
NCT01742793An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)
NCT02471391ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM)
NCT04641013Age-related Clonal Haematopoiesis in an HIV Evaluation Cohort (ARCHIVE)
NCT05154162PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI
NCT02662062Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
NCT03464942Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer
NCT04319783Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
NCT00482261A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression